This blog addresses what BPC-157 is, what the evidence actually shows, and why I do not currently offer it as a treatment at NTXMSK
Current protocols draw from animal studies, practitioner experience, and a small number of early-stage human pilots
In trials with patients with type 2 diabetes and overweight/obesity, after 16 weeks of treatment with Danuglipron, the high-dose (120 mg twice daily) group showed an average weight loss of 4.2 kg and a reduction in HbA1c levels by 1.2% compared to the placebo group
GSH levels were measured in the ELF, bronchoalveolar lavage cells, plasma, and tissues
Expert analysis of pricing, benefits, and which peptide works best for your
doi: 10.1056/NEJMoa1302369 176 JohnsonDBCarlsonJAElvinJAVergilioJ-ASuhJRamkissoonSet al